Miller Investment Management’s VanEck Biotech ETF BBH Stock Holding History

Miller Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.77M	Sell	38,226 -736	-2%	-$138K	0.71%	21
2026 Q1	$7.33M	Buy	38,962 +37	+0.1%	+$7.13K	0.73%	21
2025 Q4	$7.37M	Sell	38,925 -41,833	-52%	-$7.74M	0.72%	24
2025 Q3	$13.4M	Sell	80,758 -674	-0.8%	-$110K	1.34%	17
2025 Q2	$12.5M	Sell	81,432 -10,373	-11%	-$1.54M	1.31%	17
2025 Q1	$14.4M	Sell	91,805 -394	-0.4%	-$64K	1.6%	14
2024 Q4	$14.5M	Sell	92,199 -7,614	-8%	-$1.28M	1.58%	16
2024 Q3	$17.7M	Sell	99,813 -4,197	-4%	-$745K	1.84%	13
2024 Q2	$17.5M	Buy	104,010 +784	+0.8%	+$128K	2.09%	12
2024 Q1	$17.2M	Buy	103,226 +656	+0.6%	+$109K	2.19%	12
2023 Q4	$17M	Sell	102,570 -73,079	-42%	-$11.2M	2.41%	11
2023 Q3	$27.4M	Sell	175,649 -727	-0.4%	-$116K	4.3%	5
2023 Q2	$27.5M	Buy	176,376 +68,884	+64%	+$11M	4.2%	5
2023 Q1	$17.4M	Buy	107,492 +100,869	+1,523%	+$16.3M	2.88%	9
2022 Q4	$1.06M	Buy	6,623 +3,580	+118%	+$567K	0.18%	54
2022 Q3	$428K	Buy	3,043 +1,423	+88%	+$215K	0.09%	69
2022 Q2	$236K	Buy	+1,620	New	+$241K	0.05%	86

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Miller Investment Management's BBH Position: Q2 2026 in Review

Miller Investment Management reduced its VanEck Biotech ETF (BBH) stake by 1.9% in Q2 2026, selling an estimated $138K and leaving 38,226 shares worth $7.77M. The position accounts for 0.71% of the portfolio, ranked #21.

Miller Investment Management first reported a position in BBH in Q2 2022 and has held it in 17 quarters since. The position peaked at $27.5M in Q2 2023. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Miller Investment Management held 38,226 shares of VanEck Biotech ETF worth $7.77M as of Q2 2026.
Miller Investment Management sold 736 VanEck Biotech ETF shares in Q2 2026, an estimated $138K.
VanEck Biotech ETF made up 0.71% of Miller Investment Management's portfolio in Q2 2026, its #21 holding.
Miller Investment Management first reported a position in VanEck Biotech ETF in Q2 2022 and has held it in 17 quarters since.
Miller Investment Management's VanEck Biotech ETF position peaked at $27.5M in Q2 2023.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Miller Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.